Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AbbVie (NY: ABBV)
92.60 USD  -0.41 (-0.44%)
Official Closing Price  /  Updated: 8:04 PM EDT, Apr 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 4,754,776
Open 93.41
Bid (Size) 92.49 (100)
Ask (Size) 93.77 (200)
Prev. Close 93.01
Today's Range 92.02 - 93.80
52wk Range 63.29 - 125.86
Shares Outstanding 1,586,687,236
Dividend Yield 2.89%
Performance
YTD
-5.90%
-5.90%
1 Month
-17.65%
-17.65%
3 Month
-11.51%
-11.51%
6 Month
-3.64%
-3.64%
1 Year
+45.19%
+45.19%
Top News
More News
AbbVie to Present at the Deutsche Bank's 43rd Annual Health Care Conference
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Deutsche Bank's 43rd Annual Health Care Conference on Wednesday, May 9, 2018. Bill Chase, executive vice... Read More
from PR Newswire
Consolidated Research: 2018 Summary Expectations for Amazon, Rayonier, The Boeing, Sanchez Energy, AbbVie, and American Airlines Group — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Amazon.com, Inc.... Read More
from GlobeNewswire News Releases
More News
Read More
GW Pharma Spikes On Growing Likelihood FDA Will OK Cannabis-Based Med
from Investor's Business Daily
Quotidian Technical Highlights on Selected Drug Makers Stocks -- AbbVie, Biostar Pharma, Bristol-Myers Squibb, and Eli Lilly
from PR Newswire
China vows to cut auto tariffs, markets surge
category Market News
from MarketMinute.com Market Updates
Emerging Advanced Resources Could Rock The Canadian Cannabis Industry
from PR Newswire
Will These Biotechs Light The Way For Cannabis-Based Drugs?
from Investor's Business Daily
FOCUS-Germany's Merck seeks partners for cancer and immune system drugs
category companyNews
from Reuters: Company News
FDA staff cites safety issues for Lilly, Incyte's rheumatoid arthritis drug
category companyNews
from Reuters: Company News
AbbVie Scores Relative Strength Rating Upgrade; Hits Key Threshold
from Investor's Business Daily
Shire faces criticism on CEO pay policy as crunch week looms
category companyNews
from Reuters: Company News
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial